Log in

Actelion Stock Price, Forecast & Analysis (OTCMKTS:ALIOF)

$278.50
0.00 (0.00 %)
(As of 10/17/2019)
Today's Range
$278.50
Now: $278.50
$278.50
50-Day Range
$278.50
MA: $278.50
$278.50
52-Week Range
$138.01
Now: $278.50
$286.30
VolumeN/A
Average VolumeN/A
Market Capitalization$29.89 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.72
Actelion Ltd. invests in companies that specialize in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller, and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland.

Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ALIOF
CUSIPN/A
CIKN/A
Phone41-61-565-6565

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.46 billion

Profitability

Miscellaneous

EmployeesN/A
Market Cap$29.89 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive ALIOF News and Ratings via Email

Sign-up to receive the latest news and ratings for ALIOF and its competitors with MarketBeat's FREE daily newsletter.


Actelion (OTCMKTS:ALIOF) Frequently Asked Questions

What is Actelion's stock symbol?

Actelion trades on the OTCMKTS under the ticker symbol "ALIOF."

How were Actelion's earnings last quarter?

Actelion Ltd (OTCMKTS:ALIOF) posted its quarterly earnings data on Monday, February, 16th. The company reported $0.87 earnings per share for the quarter, missing the consensus estimate of $1.09 by $0.22. The company had revenue of $501.50 million for the quarter, compared to analyst estimates of $546.30 million. View Actelion's Earnings History.

Has Actelion been receiving favorable news coverage?

News stories about ALIOF stock have trended very negative on Sunday, InfoTrie Sentiment reports. The research firm rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Actelion earned a media sentiment score of -3.5 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for Actelion.

Who are some of Actelion's key competitors?

What other stocks do shareholders of Actelion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Actelion investors own include Kamada (KMDA), Shire (SHPG), Neurotrope (NTRP), Voyager Therapeutics (VYGR), Align Technology (ALGN), BioMarin Pharmaceutical (BMRN), GALAPAGOS NV/S (GLPG), Illumina (ILMN), Johnson & Johnson (JNJ) and Genmab A/S (GNMSF).

Who are Actelion's key executives?

Actelion's management team includes the folowing people:
  • Nicholas Franco, Chief Business Development Officer & EVP
  • Christian Albrich, VP & Head-Global Human Resources

How do I buy shares of Actelion?

Shares of ALIOF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Actelion's stock price today?

One share of ALIOF stock can currently be purchased for approximately $278.50.

How big of a company is Actelion?

Actelion has a market capitalization of $29.89 billion and generates $2.46 billion in revenue each year. View Additional Information About Actelion.

What is Actelion's official website?

The official website for Actelion is http://www.actelion.com/.

How can I contact Actelion?

Actelion's mailing address is Gewerbestrasse 16, Allschwil V8, 4123. The company can be reached via phone at 41-61-565-6565 or via email at [email protected]


MarketBeat Community Rating for Actelion (OTCMKTS ALIOF)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  89 (Vote Outperform)
Underperform Votes:  123 (Vote Underperform)
Total Votes:  212
MarketBeat's community ratings are surveys of what our community members think about Actelion and other stocks. Vote "Outperform" if you believe ALIOF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALIOF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/17/2019 by MarketBeat.com Staff

Featured Article: What are the FAANG Stocks?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel